E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/1/2006 in the Prospect News Biotech Daily.

OccuLogix net revenues down for the third quarter

By Lisa Kerner

Charlotte, N.C., Nov. 1 - OccuLogix, Inc.'s net revenues for the third quarter were down at $85,444, from $632,330 in the third quarter of 2006.

The company reported a net loss of $3.6 million, or $0.08 per share, compared with a net loss of $2.9 million, or $0.07 share, in the prior-year period.

The Toronto-based health care company had cash and cash equivalents and short-term investments of $20.2 million at Sept. 30.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.